Tevogen Bio Holdings Inc., A Cell Therapy Company, Announces Completion Of Business Combination And Is To Be Listed On Nasdaq Under Ticker “TVGN”
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for large patient
